US Patent Litigations are now available. Check here

EP2433665

BOEHRINGER INGELHEIM PHARMA
Application Number
EP11194615A
Filing Date
Mar 11, 2009
Status
Revoked
Aug 21, 2024
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2433665B1 was granted on Aug 7, 2019 by Boehringer Ingelheim Pharma The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS2569720
N/A
OppositionUS5797391A
N/A
OppositionWO2007118801
N/A
OppositionUS5492143
N/A
OppositionUS5685294
N/A
OppositionDE19828597
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.